{"database": "lobbying", "table": "lobbying_activities", "rows": [[1839355, "211be196-01d4-4d8c-89f0-d9db9a52bf70", "Q2", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2016, "second_quarter", "FOO", "*Adequate FDA resources to implement GMP rules for dietary supplements and to provide adequate funds for full inspection of dietary supplement manufacturers.\n*Support for prompt publication of NDI Guidance from FDA\n*Full implementation of DASCA (HR 4771/S2012)\n*Inclusion of the multivitamin in SNAP legislation in 2018\n*Federal solution to gmo labeling issues for food products", "HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2016-07-11T15:02:27.527000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1839355"], "units": {}, "query_ms": 0.8867860306054354, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}